Subthalamic Gamma Knife Radiosurgery in Parkinson's Disease: A Cautionary Tale
- PMID: 32101861
- DOI: 10.1159/000505709
Subthalamic Gamma Knife Radiosurgery in Parkinson's Disease: A Cautionary Tale
Abstract
Introduction: Deep brain stimulation (DBS) targeting the subthalamic nucleus (STN) has been shown to reliably improve several symptoms of Parkinson's disease (PD) in appropriately selected patients. Various factors may preclude patients from undergoing DBS and for them, non-invasive lesion-based therapies such as focused ultrasound and Gamma Knife (GK) radiosurgery may present a safer alternative.
Materials and methods: Based on preliminary positive reports of STN GK for PD, we conducted a prospective, open-label, single-center, pilot study in PD patients deemed potential candidates for unilateral DBS based on their disease characteristics, but contraindicated due to age >74, an irreversible bleeding diathesis, or significant comorbid medical disease. Stereotactic MRI-guided GK radiosurgery was performed using a single 110- or 120-Gy dose targeting the STN contralateral to the more symptomatic extremity. Clinical follow-up and imaging assessed the safety and efficacy of the procedure over a 12-month period.
Results: Four PD patients with medication-refractory tremors and disabling dyskinesias underwent unilateral STN GK radiosurgery. Contraindications to DBS included high-risk comorbid cardiovas-cular disease in 3 patients and an irreversible bleeding diathesis in 1. There were no immediate post-procedural adverse events. One patient who underwent left STN GK radiosurgery developed right hemiparesis and dysarthria 7 months post-procedure followed by hospitalization at 9 months for bacterial endocarditis and liver failure from which he died. The remaining 3 patients were free of adverse events up to 12 months post-procedure and experienced a reduction in contralateral rigidity, bradykinesia, and tremor. Upon extended follow-up, 2 patients developed subacute worsening of gait. One died at 16 months due to complications of a fall whereas the other saw no change in gait up to 42 months post-procedure. All 3 patients with adverse events demonstrated a hyper-response in the targeted area on follow-up neuroimaging.
Discussion/conclusion: Despite the potential for clinical improvement, our results suggest that unilateral STN GK radiosurgery should be approached cautiously in medically frail PD patients who may be at higher risk of GK hyper-response and neurologic complications.
Keywords: Adverse radiation effects; Gamma Knife radiosurgery; Parkinson’s disease; Subthalamic nucleus.
© 2020 S. Karger AG, Basel.
Comment in
-
Is Glutamine Responsible for the Radiosensitivity of Subthalamic Nucleus?Stereotact Funct Neurosurg. 2021;99(2):176-177. doi: 10.1159/000510889. Epub 2020 Nov 23. Stereotact Funct Neurosurg. 2021. PMID: 33227792 Free PMC article. No abstract available.
Similar articles
-
Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.Arch Neurol. 2005 Apr;62(4):554-60. doi: 10.1001/archneur.62.4.554. Arch Neurol. 2005. PMID: 15824252 Clinical Trial.
-
Is staged bilateral thalamic radiosurgery an option for otherwise surgically ineligible patients with medically refractory bilateral tremor?J Neurosurg. 2018 Feb;128(2):617-626. doi: 10.3171/2016.11.JNS162044. Epub 2017 Apr 7. J Neurosurg. 2018. PMID: 28387629
-
A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan.Acta Neurochir (Wien). 2020 May;162(5):1067-1076. doi: 10.1007/s00701-020-04269-x. Epub 2020 Feb 26. Acta Neurochir (Wien). 2020. PMID: 32103343 Free PMC article.
-
Radiosurgical Subthalamic Nucleotomy.Prog Neurol Surg. 2018;33:158-167. doi: 10.1159/000481084. Epub 2018 Jan 12. Prog Neurol Surg. 2018. PMID: 29332081 Review.
-
Role of Gamma Knife Radiosurgery in the Management of Functional Disorders - A Literature Review.Neurol India. 2023 Mar-Apr;71(Supplement):S49-S58. doi: 10.4103/0028-3886.373644. Neurol India. 2023. PMID: 37026334 Review.
Cited by
-
An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation.Front Surg. 2022 Sep 23;9:863921. doi: 10.3389/fsurg.2022.863921. eCollection 2022. Front Surg. 2022. PMID: 36211256 Free PMC article. Review.
-
Is Glutamine Responsible for the Radiosensitivity of Subthalamic Nucleus?Stereotact Funct Neurosurg. 2021;99(2):176-177. doi: 10.1159/000510889. Epub 2020 Nov 23. Stereotact Funct Neurosurg. 2021. PMID: 33227792 Free PMC article. No abstract available.
-
The Effectiveness and Toxicity of Frameless CyberKnife Based Radiosurgery for Parkinson's Disease-Phase II Study.Biomedicines. 2023 Jan 20;11(2):288. doi: 10.3390/biomedicines11020288. Biomedicines. 2023. PMID: 36830825 Free PMC article.
-
Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments.J Pers Med. 2021 Jul 10;11(7):650. doi: 10.3390/jpm11070650. J Pers Med. 2021. PMID: 34357117 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical